Results 51 to 60 of about 99,781 (250)
Faecal shedding of campylobacteria among domestic and wild animals from an urban coastal area
Austral Journal of Veterinary Sciences, 2019 Campylobacter jejuni and Campylobacter coli are the leading cause of food-related diarrhea worldwide. However, other campylobacteria such as other Campylobacter spp., Arcobacter spp. and Helicobacter spp.
Arturo Levican +7 more
doaj +1 more source
Helicobacter spp. other than Helicobacter pylori
Helicobacter, 2010 AbstractOver the last 12 months, new insights into the association of non‐Helicobacter pylori Helicobacters with a range of human diseases in children and adults, including hepatobiliary disease, Crohn’s disease, sepsis, and gastric disease were published. Studies investigating the presence of non‐H.
Goldman, Cinthia Gabriela +1 more
openaire +3 more sources
Advanced NanoBiomed Research, EarlyView.This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari +5 more
wiley +1 more source
mBio, 2018 Present in every kingdom of life, generally in multiple copies, DEAD-box RNA helicases are specialized enzymes that unwind RNA secondary structures. They play major roles in mRNA decay, ribosome biogenesis, and adaptation to cold temperatures.
Lamya El Mortaji +7 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
Armeniaspirol A: a novel anti‐Helicobacter pylori agent
Microbial Biotechnology, 2022 Summary Antibiotic resistance in Helicobacter pylori has been growing worldwide with current treatment regimens. Development of new compounds for treatment of H.
Jia Jia +8 more
doaj +1 more source
GLP‐1 agonists and the gut microbiome: A bidirectional relationship
British Journal of Clinical Pharmacology, EarlyView.Abstract Glucagon‐like peptide‐1 (GLP‐1) receptor agonists have transformed the management of type 2 diabetes mellitus (T2DM) and obesity, yet their interactions with the gut microbiome remain an emerging frontier in pharmacological and metabolic research.
Srinivas Kamath +2 more
wiley +1 more source
Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine
BMEMat, EarlyView.Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo +9 more
wiley +1 more source
Evolutionary Applications, 2020 We present a novel method for taxon selection, the aim being to minimize problems arising from highly recombinant species such as Helicobacter pylori.
Binit Lamichhane +4 more
doaj +1 more source
The ageing holobiont: crosstalk between telomere dynamics, oxidative stress and the gut microbiome
Biological Reviews, EarlyView.ABSTRACT The gut tissue is at the frontline of early onset of ageing. It exhibits high cell turnover rates and rapid telomere shortening, which can have systemic effects on the developing or senescing organism. We conducted a literature review of studies on the crosstalk between telomere length dynamics, telomerase activity, oxidative stress, and gut ...
Michael L. Pepke +2 more
wiley +1 more source